Want to join the conversation?
Segment-wise, 1Q16 revenue from $A's Life Sciences and Applied Markets Group (LSAG) declined 4% YoverY to $526MM, driven by the softness in the applied markets. Revenue from the CrossLab Group (ACG) grew 4% YoverY to $344MM, while Diagnostics and Genomics Group (DGG) increased 7% to $158MM.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.
$VZ down more than 2% after a disappointing third quarter. A lot of uncertainty on the Yahoo deal too.
Wanna know what $TSLA announced yesterday? Watch the video!! Tesla Self-Driving Car Level 5 Autonomy. This is crazy!!